TriSalus Life Sciences
TriSalus Life Sciences raised US$75.6M in Series E funding.
Email and contact information
Company website: trisaluslifesci.com/
Decision maker info and email: SIGNUP TO UNBLOCK
Headquarters: Westminster, Colorado (United States)
Industry: Biotechnology, Developer Platform, Hardware, Medical
Business model:
Funding
- Total funding amount: $75,647,357 (in USD)
- Estimated valuation: $378,236,785.00
- Latest deal type: Series E
- First fundind year: 2022
Growth
Founders: Aravind Arepally, James E. Chomas
Top investors: MCG Capital, ORI Capital, Tullis Health Investors, KMG Capital Partners, High Country Venture
Team size: SIGNUP TO UNBLOCK
Revenue: SIGNUP TO UNBLOCK